Skip to Content

Veralox Therapeutics Raises $5.4 Million In Seed Funding

September 12, 2019

Shulman Rogers was pleased to advise our client, Veralox, in their $5.4M capital raise. A biotechnology company based in Frederick, Maryland, Veralox will use the funding to advance the development of first-in-class therapeutics to address unmet medical needs. We were thrilled to play a role in this transaction and very much look forward to their…

Read More

Has the Business Roundtable Changed the Standard for Directors’ Duties to Corporations?

September 10, 2019

On August 19, 2019, the Business Roundtable (TBR), an association of top CEOs, surprised corporate America by adopting a new “Statement on the Purpose of a Corporation,” which declared that a corporation’s purpose is a “fundamental commitment to all … stakeholders,”[1] including not only shareholders but also customers, employees, suppliers, communities and the environment. Some…

Read More
In The Community

Charity of the Month: No Warrior Left Behind

September 3, 2019

For September 2019, Shulman Rogers is proud to support No Warrior Left Behind. No Warrior Left Behind, is committed to honoring, saluting, and supporting the men and women in the military and the first responders in our community who volunteer to be in harm’s way in order to serve and protect the safety and freedom…

Read More